The Gross Margin of Nymox Pharmaceutical Corp (NYMX) is N/A.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2022-12-31 | - |
2021-12-31 | - |
2020-12-31 | 50.00% |
2019-12-31 | 53.33% |
2018-12-31 | 31.82% |
2017-12-31 | 39.29% |
2016-12-31 | 94.20% |
2015-12-31 | 94.24% |
2014-12-31 | 85.42% |